Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection

Abstract Mal de Río Cuarto virus (MRCV) is a member of the genus Fijivirus of the family Reoviridae that causes a devastating disease in maize and is persistently and propagatively transmitted by planthopper vectors. Virus replication and assembly occur within viroplasms formed by viral and host pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gabriela Llauger, Demián Monti, Matías Adúriz, Ema Romão, Analía Delina Dumón, María Fernanda Mattio, Andrés Wigdorovitz, Serge Muyldermans, Cécile Vincke, Viviana Parreño, Mariana del Vas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c0685c6872914794bdfc53f26ee2fc9c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0685c6872914794bdfc53f26ee2fc9c
record_format dspace
spelling oai:doaj.org-article:c0685c6872914794bdfc53f26ee2fc9c2021-12-02T19:16:11ZDevelopment of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection10.1038/s41598-021-99275-z2045-2322https://doaj.org/article/c0685c6872914794bdfc53f26ee2fc9c2021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99275-zhttps://doaj.org/toc/2045-2322Abstract Mal de Río Cuarto virus (MRCV) is a member of the genus Fijivirus of the family Reoviridae that causes a devastating disease in maize and is persistently and propagatively transmitted by planthopper vectors. Virus replication and assembly occur within viroplasms formed by viral and host proteins. This work describes the isolation and characterization of llama-derived Nanobodies (Nbs) recognizing the major viral viroplasm component, P9-1. Specific Nbs were selected against recombinant P9-1, with affinities in the nanomolar range as measured by surface plasmon resonance. Three selected Nbs were fused to alkaline phosphatase and eGFP to develop a sandwich ELISA test which showed a high diagnostic sensitivity (99.12%, 95% CI 95.21–99.98) and specificity (100%, 95% CI 96.31–100) and a detection limit of 0.236 ng/ml. Interestingly, these Nanobodies recognized different P9-1 conformations and were successfully employed to detect P9-1 in pull-down assays of infected maize extracts. Finally, we demonstrated that fusions of the Nbs to eGFP and RFP allowed the immunodetection of virus present in phloem cells of leaf thin sections. The Nbs developed in this work will aid the study of MRCV epidemiology, assist maize breeding programs, and be valuable tools to boost fundamental research on viroplasm structure and maturation.Gabriela LlaugerDemián MontiMatías AdúrizEma RomãoAnalía Delina DumónMaría Fernanda MattioAndrés WigdorovitzSerge MuyldermansCécile VinckeViviana ParreñoMariana del VasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gabriela Llauger
Demián Monti
Matías Adúriz
Ema Romão
Analía Delina Dumón
María Fernanda Mattio
Andrés Wigdorovitz
Serge Muyldermans
Cécile Vincke
Viviana Parreño
Mariana del Vas
Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
description Abstract Mal de Río Cuarto virus (MRCV) is a member of the genus Fijivirus of the family Reoviridae that causes a devastating disease in maize and is persistently and propagatively transmitted by planthopper vectors. Virus replication and assembly occur within viroplasms formed by viral and host proteins. This work describes the isolation and characterization of llama-derived Nanobodies (Nbs) recognizing the major viral viroplasm component, P9-1. Specific Nbs were selected against recombinant P9-1, with affinities in the nanomolar range as measured by surface plasmon resonance. Three selected Nbs were fused to alkaline phosphatase and eGFP to develop a sandwich ELISA test which showed a high diagnostic sensitivity (99.12%, 95% CI 95.21–99.98) and specificity (100%, 95% CI 96.31–100) and a detection limit of 0.236 ng/ml. Interestingly, these Nanobodies recognized different P9-1 conformations and were successfully employed to detect P9-1 in pull-down assays of infected maize extracts. Finally, we demonstrated that fusions of the Nbs to eGFP and RFP allowed the immunodetection of virus present in phloem cells of leaf thin sections. The Nbs developed in this work will aid the study of MRCV epidemiology, assist maize breeding programs, and be valuable tools to boost fundamental research on viroplasm structure and maturation.
format article
author Gabriela Llauger
Demián Monti
Matías Adúriz
Ema Romão
Analía Delina Dumón
María Fernanda Mattio
Andrés Wigdorovitz
Serge Muyldermans
Cécile Vincke
Viviana Parreño
Mariana del Vas
author_facet Gabriela Llauger
Demián Monti
Matías Adúriz
Ema Romão
Analía Delina Dumón
María Fernanda Mattio
Andrés Wigdorovitz
Serge Muyldermans
Cécile Vincke
Viviana Parreño
Mariana del Vas
author_sort Gabriela Llauger
title Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
title_short Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
title_full Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
title_fullStr Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
title_full_unstemmed Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
title_sort development of nanobodies against mal de río cuarto virus major viroplasm protein p9-1 for diagnostic sandwich elisa and immunodetection
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c0685c6872914794bdfc53f26ee2fc9c
work_keys_str_mv AT gabrielallauger developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT demianmonti developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT matiasaduriz developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT emaromao developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT analiadelinadumon developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT mariafernandamattio developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT andreswigdorovitz developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT sergemuyldermans developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT cecilevincke developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT vivianaparreno developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
AT marianadelvas developmentofnanobodiesagainstmalderiocuartovirusmajorviroplasmproteinp91fordiagnosticsandwichelisaandimmunodetection
_version_ 1718376993925365760